Literature DB >> 11851578

Fatal inhalational anthrax in a 94-year-old Connecticut woman.

Lydia A Barakat1, Howard L Quentzel, John A Jernigan, David L Kirschke, Kevin Griffith, Stephen M Spear, Katherine Kelley, Diane Barden, Donald Mayo, David S Stephens, Tanja Popovic, Chung Marston, Sherif R Zaki, Jeanette Guarner, Wun-Ju Shieh, H Wayne Carver, Richard F Meyer, David L Swerdlow, Eric E Mast, James L Hadler.   

Abstract

We describe the 11th case of bioterrorism-related inhalational anthrax reported in the United States. The presenting clinical features of this 94-year-old woman were subtle and nondistinctive. The diagnosis was recognized because blood cultures were obtained prior to administration of antibiotics, emphasizing the importance of this diagnostic test in evaluating ill patients who have been exposed to Bacillus anthracis. The patient's clinical course was characterized by progression of respiratory insufficiency, pleural effusions and pulmonary edema, and, ultimately, death. Although her B anthracis bacteremia was rapidly sterilized after initiation of antibiotic therapy, viable B anthracis was present in postmortem mediastinal lymph node specimens. The source of exposure to B anthracis in this patient is not known. Exposure to mail that was cross-contaminated as it passed through postal facilities contaminated with B anthracis spores is one hypothesis under investigation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11851578     DOI: 10.1001/jama.287.7.863

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  50 in total

1.  Inhalational anthrax: radiologic and pathologic findings in two cases.

Authors:  Bradford J Wood; Bryan DeFranco; Mary Ripple; Martin Topiel; Carlos Chiriboga; Venkat Mani; Kevin Barry; Dave Fowler; Henry Masur; Luciana Borio
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

2.  Pathophysiological manifestations in mice exposed to anthrax lethal toxin.

Authors:  Nathan C Culley; David M Pinson; Anuradha Chakrabarty; Matthew S Mayo; Steven M LeVine
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Rapid assessment of agents of biological terrorism: defining the differential diagnosis of inhalational anthrax using electronic communication in a practice-based research network.

Authors:  Jonathan L Temte; Anna Lisa Anderson
Journal:  Ann Fam Med       Date:  2004 Sep-Oct       Impact factor: 5.166

4.  The primary care differential diagnosis of inhalational anthrax.

Authors:  Jonathan L Temte; Andrew R Zinkel
Journal:  Ann Fam Med       Date:  2004 Sep-Oct       Impact factor: 5.166

Review 5.  Criteria for validation of methods in microbial forensics.

Authors:  Bruce Budowle; Steven E Schutzer; Stephen A Morse; Kenneth F Martinez; Ranajit Chakraborty; Babetta L Marrone; Sharon L Messenger; Randall S Murch; Paul J Jackson; Phillip Williamson; Rockne Harmon; Stephan P Velsko
Journal:  Appl Environ Microbiol       Date:  2008-07-25       Impact factor: 4.792

6.  Acquired coagulant factor VIII deficiency induced by Bacillus anthracis lethal toxin in mice.

Authors:  Der-Shan Sun; Po-Chien Lee; Jyh-Hwa Kau; Yung-Luen Shih; Hsin-Hsien Huang; Chen-Ru Li; Chin-Cheng Lee; Yu-Ping Wu; Kuo-Ching Chen; Hsin-Hou Chang
Journal:  Virulence       Date:  2015-04-23       Impact factor: 5.882

7.  Sepsis and pathophysiology of anthrax in a nonhuman primate model.

Authors:  Deborah J Stearns-Kurosawa; Florea Lupu; Fletcher B Taylor; Gary Kinasewitz; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

8.  Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.

Authors:  Demetrios N Kyriacou; Debra Dobrez; Jorge P Parada; Justin M Steinberg; Adam Kahn; Charles L Bennett; Brian P Schmitt
Journal:  Biosecur Bioterror       Date:  2012-07-30

9.  Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.

Authors:  Jennifer L Williams; Stephanie S Noviello; Kevin S Griffith; Heather Wurtzel; Jennifer Hamborsky; Joseph F Perz; Ian T Williams; James L Hadler; David L Swerdlow; Renee Ridzon
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

10.  A two-component direct fluorescent-antibody assay for rapid identification of Bacillus anthracis.

Authors:  Barun K De; Sandra L Bragg; Gary N Sanden; Kathy E Wilson; Lois A Diem; Chung K Marston; Alex R Hoffmaster; Gwen A Barnett; Robbin S Weyant; Teresa G Abshire; John W Ezzell; Tanja Popovic
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.